TRAFFIC ADVISORY:

President Trump is scheduled to be in Philadelphia on Tuesday, September 15, 2020 at The National Constitution Center (NCC) in the Independence Mall area. Increased police presence is anticipated in Center City throughout Tuesday afternoon and evening. Please allow extra time if you are going to Wills Eye. Please be advised of area street closures to vehicles beginning at 1:00PM on Tuesday 9/15. Pedestrian access will also be limited in the area. This is subject to change and area restrictions, which could widen, will be lifted once the President departs the NCC. There are also demonstrations planned for Tuesday 9/15 around Independence Mall as well as City Avenue.

Clinical Trials Enrollment Ocular Oncology

RESEARCH_Secondary Page Header
Age Related Macular Degeneration
RESEARCH
Advancing Science • Fostering Collaboration • Inspiring Innovation
Age Related Macular Degeneration

Wills Eye Ocular Oncology Studies

 

Aura Nanoparticle Therapy in the Management of Choroidal Melanoma and Metastasis
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

Potential of Aqueous Humor for Uveal Melanoma
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

Potential of Aqueous Humor for Retinoblastoma
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

A Randomized Clinical Trial Evaluating Anti-VEGF vs. Sustained-Release Corticosteroid vs. Observation for Prevention of Visual Acuity Loss due to Radiation Retinopathy
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

Phase II Randomized Trial of Radiotherapy Followed by Intravitreal Aflibercept Injection for Patients with Ocular Melanoma
Wills Eye Study Doctors: Carol L. Shields, MD and Sara E. Lally, MD

To learn more about the studies listed above, please contact:

Lisa Cotelesa
Ocular Oncology Study Coordinator
Email: lisac@shields.md
Phone: (215) 928-3108